img

Global Valsartan Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Valsartan Drug Market Insights, Forecast to 2034

Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.
Global Valsartan Drug market is expected to reach to US$ 597 million in 2024, with a positive growth of %, compared with US$ 589 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Valsartan Drug industry is evaluated to reach US$ 866.2 million in 2029. The CAGR will be 6.4% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Valsartan Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Valsartan Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Sun Pharmaceutical
Teva
Mylan
Alembic Pharmaceuticals
Lupin
Aurobindo Pharma
Macleods Pharmaceuticals
HETERO
Torrent Pharmaceuticals
Huaren Pharmaceutical
Jubilant Pharma
Amneal Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Square Pharmaceuticals
Unichem Laboratories
Segment by Type
40 mg Tablets
80 mg Tablets
160 mg Tablets
320 mg Tablets

Segment by Application


Hypertension
Heart Failure
Heart Attack

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Valsartan Drug plant distribution, commercial date of Valsartan Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Valsartan Drug introduction, etc. Valsartan Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Valsartan Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Valsartan Drug Product Introduction
1.2 Market by Type
1.2.1 Global Valsartan Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 40 mg Tablets
1.2.3 80 mg Tablets
1.2.4 160 mg Tablets
1.2.5 320 mg Tablets
1.3 Market by Application
1.3.1 Global Valsartan Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hypertension
1.3.3 Heart Failure
1.3.4 Heart Attack
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Valsartan Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Valsartan Drug Revenue by Region
2.2.1 Global Valsartan Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Valsartan Drug Revenue by Region (2018-2024)
2.2.3 Global Valsartan Drug Revenue by Region (2024-2029)
2.2.4 Global Valsartan Drug Revenue Market Share by Region (2018-2029)
2.3 Global Valsartan Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Valsartan Drug Sales by Region
2.4.1 Global Valsartan Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Valsartan Drug Sales by Region (2018-2024)
2.4.3 Global Valsartan Drug Sales by Region (2024-2029)
2.4.4 Global Valsartan Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Valsartan Drug Sales by Manufacturers
3.1.1 Global Valsartan Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Valsartan Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Valsartan Drug in 2022
3.2 Global Valsartan Drug Revenue by Manufacturers
3.2.1 Global Valsartan Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Valsartan Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Valsartan Drug Revenue in 2022
3.3 Global Key Players of Valsartan Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Valsartan Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Valsartan Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Valsartan Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Valsartan Drug, Product Offered and Application
3.8 Global Key Manufacturers of Valsartan Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Valsartan Drug Sales by Type
4.1.1 Global Valsartan Drug Historical Sales by Type (2018-2024)
4.1.2 Global Valsartan Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Valsartan Drug Sales Market Share by Type (2018-2029)
4.2 Global Valsartan Drug Revenue by Type
4.2.1 Global Valsartan Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Valsartan Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Valsartan Drug Revenue Market Share by Type (2018-2029)
4.3 Global Valsartan Drug Price by Type
4.3.1 Global Valsartan Drug Price by Type (2018-2024)
4.3.2 Global Valsartan Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Valsartan Drug Sales by Application
5.1.1 Global Valsartan Drug Historical Sales by Application (2018-2024)
5.1.2 Global Valsartan Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Valsartan Drug Sales Market Share by Application (2018-2029)
5.2 Global Valsartan Drug Revenue by Application
5.2.1 Global Valsartan Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Valsartan Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Valsartan Drug Revenue Market Share by Application (2018-2029)
5.3 Global Valsartan Drug Price by Application
5.3.1 Global Valsartan Drug Price by Application (2018-2024)
5.3.2 Global Valsartan Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Valsartan Drug Market Size by Type
6.1.1 US & Canada Valsartan Drug Sales by Type (2018-2029)
6.1.2 US & Canada Valsartan Drug Revenue by Type (2018-2029)
6.2 US & Canada Valsartan Drug Market Size by Application
6.2.1 US & Canada Valsartan Drug Sales by Application (2018-2029)
6.2.2 US & Canada Valsartan Drug Revenue by Application (2018-2029)
6.3 US & Canada Valsartan Drug Market Size by Country
6.3.1 US & Canada Valsartan Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Valsartan Drug Sales by Country (2018-2029)
6.3.3 US & Canada Valsartan Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Valsartan Drug Market Size by Type
7.1.1 Europe Valsartan Drug Sales by Type (2018-2029)
7.1.2 Europe Valsartan Drug Revenue by Type (2018-2029)
7.2 Europe Valsartan Drug Market Size by Application
7.2.1 Europe Valsartan Drug Sales by Application (2018-2029)
7.2.2 Europe Valsartan Drug Revenue by Application (2018-2029)
7.3 Europe Valsartan Drug Market Size by Country
7.3.1 Europe Valsartan Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Valsartan Drug Sales by Country (2018-2029)
7.3.3 Europe Valsartan Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Valsartan Drug Market Size
8.1.1 China Valsartan Drug Sales (2018-2029)
8.1.2 China Valsartan Drug Revenue (2018-2029)
8.2 China Valsartan Drug Market Size by Application
8.2.1 China Valsartan Drug Sales by Application (2018-2029)
8.2.2 China Valsartan Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Valsartan Drug Market Size by Type
9.1.1 Asia Valsartan Drug Sales by Type (2018-2029)
9.1.2 Asia Valsartan Drug Revenue by Type (2018-2029)
9.2 Asia Valsartan Drug Market Size by Application
9.2.1 Asia Valsartan Drug Sales by Application (2018-2029)
9.2.2 Asia Valsartan Drug Revenue by Application (2018-2029)
9.3 Asia Valsartan Drug Sales by Region
9.3.1 Asia Valsartan Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Valsartan Drug Revenue by Region (2018-2029)
9.3.3 Asia Valsartan Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Valsartan Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Valsartan Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Valsartan Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Valsartan Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Valsartan Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Valsartan Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Valsartan Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Valsartan Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Valsartan Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Valsartan Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Sun Pharmaceutical
11.2.1 Sun Pharmaceutical Company Information
11.2.2 Sun Pharmaceutical Overview
11.2.3 Sun Pharmaceutical Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sun Pharmaceutical Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sun Pharmaceutical Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Alembic Pharmaceuticals
11.5.1 Alembic Pharmaceuticals Company Information
11.5.2 Alembic Pharmaceuticals Overview
11.5.3 Alembic Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Alembic Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Alembic Pharmaceuticals Recent Developments
11.6 Lupin
11.6.1 Lupin Company Information
11.6.2 Lupin Overview
11.6.3 Lupin Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Lupin Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lupin Recent Developments
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Information
11.7.2 Aurobindo Pharma Overview
11.7.3 Aurobindo Pharma Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Aurobindo Pharma Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Aurobindo Pharma Recent Developments
11.8 Macleods Pharmaceuticals
11.8.1 Macleods Pharmaceuticals Company Information
11.8.2 Macleods Pharmaceuticals Overview
11.8.3 Macleods Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Macleods Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Macleods Pharmaceuticals Recent Developments
11.9 HETERO
11.9.1 HETERO Company Information
11.9.2 HETERO Overview
11.9.3 HETERO Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 HETERO Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 HETERO Recent Developments
11.10 Torrent Pharmaceuticals
11.10.1 Torrent Pharmaceuticals Company Information
11.10.2 Torrent Pharmaceuticals Overview
11.10.3 Torrent Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Torrent Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Torrent Pharmaceuticals Recent Developments
11.11 Huaren Pharmaceutical
11.11.1 Huaren Pharmaceutical Company Information
11.11.2 Huaren Pharmaceutical Overview
11.11.3 Huaren Pharmaceutical Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Huaren Pharmaceutical Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Huaren Pharmaceutical Recent Developments
11.12 Jubilant Pharma
11.12.1 Jubilant Pharma Company Information
11.12.2 Jubilant Pharma Overview
11.12.3 Jubilant Pharma Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Jubilant Pharma Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Jubilant Pharma Recent Developments
11.13 Amneal Pharmaceuticals
11.13.1 Amneal Pharmaceuticals Company Information
11.13.2 Amneal Pharmaceuticals Overview
11.13.3 Amneal Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Amneal Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Amneal Pharmaceuticals Recent Developments
11.14 Zhejiang Huahai Pharmaceutical
11.14.1 Zhejiang Huahai Pharmaceutical Company Information
11.14.2 Zhejiang Huahai Pharmaceutical Overview
11.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Zhejiang Huahai Pharmaceutical Recent Developments
11.15 Square Pharmaceuticals
11.15.1 Square Pharmaceuticals Company Information
11.15.2 Square Pharmaceuticals Overview
11.15.3 Square Pharmaceuticals Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Square Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Square Pharmaceuticals Recent Developments
11.16 Unichem Laboratories
11.16.1 Unichem Laboratories Company Information
11.16.2 Unichem Laboratories Overview
11.16.3 Unichem Laboratories Valsartan Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Unichem Laboratories Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Unichem Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Valsartan Drug Industry Chain Analysis
12.2 Valsartan Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Valsartan Drug Production Mode & Process
12.4 Valsartan Drug Sales and Marketing
12.4.1 Valsartan Drug Sales Channels
12.4.2 Valsartan Drug Distributors
12.5 Valsartan Drug Customers
13 Market Dynamics
13.1 Valsartan Drug Industry Trends
13.2 Valsartan Drug Market Drivers
13.3 Valsartan Drug Market Challenges
13.4 Valsartan Drug Market Restraints
14 Key Findings in The Global Valsartan Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Valsartan Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 40 mg Tablets
Table 3. Major Manufacturers of 80 mg Tablets
Table 4. Major Manufacturers of 160 mg Tablets
Table 5. Major Manufacturers of 320 mg Tablets
Table 6. Global Valsartan Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Valsartan Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Valsartan Drug Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Valsartan Drug Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Valsartan Drug Revenue Market Share by Region (2018-2024)
Table 11. Global Valsartan Drug Revenue Market Share by Region (2024-2029)
Table 12. Global Valsartan Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Valsartan Drug Sales by Region (2018-2024) & (K Units)
Table 14. Global Valsartan Drug Sales by Region (2024-2029) & (K Units)
Table 15. Global Valsartan Drug Sales Market Share by Region (2018-2024)
Table 16. Global Valsartan Drug Sales Market Share by Region (2024-2029)
Table 17. Global Valsartan Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Valsartan Drug Sales Share by Manufacturers (2018-2024)
Table 19. Global Valsartan Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Valsartan Drug Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Valsartan Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Valsartan Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 23. Global Valsartan Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Valsartan Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan Drug as of 2022)
Table 25. Global Key Manufacturers of Valsartan Drug, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Valsartan Drug, Product Offered and Application
Table 27. Global Key Manufacturers of Valsartan Drug, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Valsartan Drug Sales by Type (2018-2024) & (K Units)
Table 30. Global Valsartan Drug Sales by Type (2024-2029) & (K Units)
Table 31. Global Valsartan Drug Sales Share by Type (2018-2024)
Table 32. Global Valsartan Drug Sales Share by Type (2024-2029)
Table 33. Global Valsartan Drug Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Valsartan Drug Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Valsartan Drug Revenue Share by Type (2018-2024)
Table 36. Global Valsartan Drug Revenue Share by Type (2024-2029)
Table 37. Valsartan Drug Price by Type (2018-2024) & (USD/Unit)
Table 38. Global Valsartan Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 39. Global Valsartan Drug Sales by Application (2018-2024) & (K Units)
Table 40. Global Valsartan Drug Sales by Application (2024-2029) & (K Units)
Table 41. Global Valsartan Drug Sales Share by Application (2018-2024)
Table 42. Global Valsartan Drug Sales Share by Application (2024-2029)
Table 43. Global Valsartan Drug Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Valsartan Drug Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Valsartan Drug Revenue Share by Application (2018-2024)
Table 46. Global Valsartan Drug Revenue Share by Application (2024-2029)
Table 47. Valsartan Drug Price by Application (2018-2024) & (USD/Unit)
Table 48. Global Valsartan Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 49. US & Canada Valsartan Drug Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Valsartan Drug Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Valsartan Drug Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Valsartan Drug Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Valsartan Drug Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Valsartan Drug Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Valsartan Drug Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Valsartan Drug Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Valsartan Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Valsartan Drug Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Valsartan Drug Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Valsartan Drug Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Valsartan Drug Sales by Country (2024-2029) & (K Units)
Table 62. Europe Valsartan Drug Sales by Type (2018-2024) & (K Units)
Table 63. Europe Valsartan Drug Sales by Type (2024-2029) & (K Units)
Table 64. Europe Valsartan Drug Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Valsartan Drug Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Valsartan Drug Sales by Application (2018-2024) & (K Units)
Table 67. Europe Valsartan Drug Sales by Application (2024-2029) & (K Units)
Table 68. Europe Valsartan Drug Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Valsartan Drug Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Valsartan Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Valsartan Drug Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Valsartan Drug Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Valsartan Drug Sales by Country (2018-2024) & (K Units)
Table 74. Europe Valsartan Drug Sales by Country (2024-2029) & (K Units)
Table 75. China Valsartan Drug Sales by Type (2018-2024) & (K Units)
Table 76. China Valsartan Drug Sales by Type (2024-2029) & (K Units)
Table 77. China Valsartan Drug Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Valsartan Drug Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Valsartan Drug Sales by Application (2018-2024) & (K Units)
Table 80. China Valsartan Drug Sales by Application (2024-2029) & (K Units)
Table 81. China Valsartan Drug Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Valsartan Drug Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Valsartan Drug Sales by Type (2018-2024) & (K Units)
Table 84. Asia Valsartan Drug Sales by Type (2024-2029) & (K Units)
Table 85. Asia Valsartan Drug Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Valsartan Drug Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Valsartan Drug Sales by Application (2018-2024) & (K Units)
Table 88. Asia Valsartan Drug Sales by Application (2024-2029) & (K Units)
Table 89. Asia Valsartan Drug Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Valsartan Drug Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Valsartan Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Valsartan Drug Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Valsartan Drug Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Valsartan Drug Sales by Region (2018-2024) & (K Units)
Table 95. Asia Valsartan Drug Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Valsartan Drug Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Valsartan Drug Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Valsartan Drug Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Valsartan Drug Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Valsartan Drug Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Valsartan Drug Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Valsartan Drug Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Valsartan Drug Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Valsartan Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Valsartan Drug Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Valsartan Drug Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Valsartan Drug Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Valsartan Drug Sales by Country (2024-2029) & (K Units)
Table 109. Novartis Company Information
Table 110. Novartis Description and Major Businesses
Table 111. Novartis Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Novartis Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Novartis Recent Developments
Table 114. Sun Pharmaceutical Company Information
Table 115. Sun Pharmaceutical Description and Major Businesses
Table 116. Sun Pharmaceutical Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Sun Pharmaceutical Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Sun Pharmaceutical Recent Developments
Table 119. Teva Company Information
Table 120. Teva Description and Major Businesses
Table 121. Teva Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Teva Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Teva Recent Developments
Table 124. Mylan Company Information
Table 125. Mylan Description and Major Businesses
Table 126. Mylan Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Mylan Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Mylan Recent Developments
Table 129. Alembic Pharmaceuticals Company Information
Table 130. Alembic Pharmaceuticals Description and Major Businesses
Table 131. Alembic Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Alembic Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Alembic Pharmaceuticals Recent Developments
Table 134. Lupin Company Information
Table 135. Lupin Description and Major Businesses
Table 136. Lupin Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Lupin Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Lupin Recent Developments
Table 139. Aurobindo Pharma Company Information
Table 140. Aurobindo Pharma Description and Major Businesses
Table 141. Aurobindo Pharma Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Aurobindo Pharma Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Aurobindo Pharma Recent Developments
Table 144. Macleods Pharmaceuticals Company Information
Table 145. Macleods Pharmaceuticals Description and Major Businesses
Table 146. Macleods Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Macleods Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Macleods Pharmaceuticals Recent Developments
Table 149. HETERO Company Information
Table 150. HETERO Description and Major Businesses
Table 151. HETERO Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. HETERO Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. HETERO Recent Developments
Table 154. Torrent Pharmaceuticals Company Information
Table 155. Torrent Pharmaceuticals Description and Major Businesses
Table 156. Torrent Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Torrent Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Torrent Pharmaceuticals Recent Developments
Table 159. Huaren Pharmaceutical Company Information
Table 160. Huaren Pharmaceutical Description and Major Businesses
Table 161. Huaren Pharmaceutical Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Huaren Pharmaceutical Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Huaren Pharmaceutical Recent Developments
Table 164. Jubilant Pharma Company Information
Table 165. Jubilant Pharma Description and Major Businesses
Table 166. Jubilant Pharma Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Jubilant Pharma Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Jubilant Pharma Recent Developments
Table 169. Amneal Pharmaceuticals Company Information
Table 170. Amneal Pharmaceuticals Description and Major Businesses
Table 171. Amneal Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Amneal Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Amneal Pharmaceuticals Recent Developments
Table 174. Zhejiang Huahai Pharmaceutical Company Information
Table 175. Zhejiang Huahai Pharmaceutical Description and Major Businesses
Table 176. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. Zhejiang Huahai Pharmaceutical Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Zhejiang Huahai Pharmaceutical Recent Developments
Table 179. Square Pharmaceuticals Company Information
Table 180. Square Pharmaceuticals Description and Major Businesses
Table 181. Square Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 182. Square Pharmaceuticals Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Square Pharmaceuticals Recent Developments
Table 184. Unichem Laboratories Company Information
Table 185. Unichem Laboratories Description and Major Businesses
Table 186. Unichem Laboratories Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 187. Unichem Laboratories Valsartan Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 188. Unichem Laboratories Recent Developments
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Valsartan Drug Distributors List
Table 192. Valsartan Drug Customers List
Table 193. Valsartan Drug Market Trends
Table 194. Valsartan Drug Market Drivers
Table 195. Valsartan Drug Market Challenges
Table 196. Valsartan Drug Market Restraints
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Valsartan Drug Product Picture
Figure 2. Global Valsartan Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Valsartan Drug Market Share by Type in 2022 & 2029
Figure 4. 40 mg Tablets Product Picture
Figure 5. 80 mg Tablets Product Picture
Figure 6. 160 mg Tablets Product Picture
Figure 7. 320 mg Tablets Product Picture
Figure 8. Global Valsartan Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Valsartan Drug Market Share by Application in 2022 & 2029
Figure 10. Hypertension
Figure 11. Heart Failure
Figure 12. Heart Attack
Figure 13. Valsartan Drug Report Years Considered
Figure 14. Global Valsartan Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Valsartan Drug Revenue 2018-2029 (US$ Million)
Figure 16. Global Valsartan Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Valsartan Drug Revenue Market Share by Region (2018-2029)
Figure 18. Global Valsartan Drug Sales 2018-2029 ((K Units)
Figure 19. Global Valsartan Drug Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Valsartan Drug Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Valsartan Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Valsartan Drug Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Valsartan Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Valsartan Drug Sales YoY (2018-2029) & (K Units)
Figure 25. China Valsartan Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Valsartan Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Valsartan Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Valsartan Drug Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Valsartan Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Valsartan Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Valsartan Drug in the World: Market Share by Valsartan Drug Revenue in 2022
Figure 32. Global Valsartan Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Valsartan Drug Sales Market Share by Type (2018-2029)
Figure 34. Global Valsartan Drug Revenue Market Share by Type (2018-2029)
Figure 35. Global Valsartan Drug Sales Market Share by Application (2018-2029)
Figure 36. Global Valsartan Drug Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Valsartan Drug Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Valsartan Drug Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Valsartan Drug Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Valsartan Drug Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Valsartan Drug Revenue Share by Country (2018-2029)
Figure 42. US & Canada Valsartan Drug Sales Share by Country (2018-2029)
Figure 43. U.S. Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Valsartan Drug Sales Market Share by Type (2018-2029)
Figure 46. Europe Valsartan Drug Revenue Market Share by Type (2018-2029)
Figure 47. Europe Valsartan Drug Sales Market Share by Application (2018-2029)
Figure 48. Europe Valsartan Drug Revenue Market Share by Application (2018-2029)
Figure 49. Europe Valsartan Drug Revenue Share by Country (2018-2029)
Figure 50. Europe Valsartan Drug Sales Share by Country (2018-2029)
Figure 51. Germany Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 52. France Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 56. China Valsartan Drug Sales Market Share by Type (2018-2029)
Figure 57. China Valsartan Drug Revenue Market Share by Type (2018-2029)
Figure 58. China Valsartan Drug Sales Market Share by Application (2018-2029)
Figure 59. China Valsartan Drug Revenue Market Share by Application (2018-2029)
Figure 60. Asia Valsartan Drug Sales Market Share by Type (2018-2029)
Figure 61. Asia Valsartan Drug Revenue Market Share by Type (2018-2029)
Figure 62. Asia Valsartan Drug Sales Market Share by Application (2018-2029)
Figure 63. Asia Valsartan Drug Revenue Market Share by Application (2018-2029)
Figure 64. Asia Valsartan Drug Revenue Share by Region (2018-2029)
Figure 65. Asia Valsartan Drug Sales Share by Region (2018-2029)
Figure 66. Japan Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 70. India Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Valsartan Drug Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Valsartan Drug Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Valsartan Drug Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Valsartan Drug Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Valsartan Drug Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Valsartan Drug Sales Share by Country (2018-2029)
Figure 77. Brazil Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Valsartan Drug Revenue (2018-2029) & (US$ Million)
Figure 82. Valsartan Drug Value Chain
Figure 83. Valsartan Drug Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries